Related Experiment Video

Updated: Jun 29, 2026

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

Involvement of cPLA2 inhibition in dexamethasone-induced thymocyte apoptosis

B Cinque1, D Fanini, L Di Marzio

  • 1Department of Health Science, University of L'Aquila, L'Aquila, Italy.

International Journal of Immunopathology and Pharmacology
|October 4, 2008
PubMed

Insights

Pharmacological inhibition of cytoplasmic phospholipase A2 (cPLA2) in mouse thymocytes triggers apoptosis similar to dexamethasone. This effect involves sphingomyelinase activation, ceramide generation, and caspase 3 activation, highlighting cPLA2

Area of Science:

  • Cell Biology
  • Biochemistry
  • Immunology

Background:

  • Dexamethasone (Dex) is known to induce thymocyte apoptosis through various molecular pathways.
  • The precise mechanisms underlying Dex-induced thymocyte apoptosis are not fully elucidated.
  • Phospholipase A2 (PLA2) enzymes are implicated in cellular signaling and apoptosis.

Purpose of the Study:

  • To investigate the role of cytoplasmic phospholipase A2 (cPLA2) in dexamethasone-induced thymocyte apoptosis.
  • To determine if inhibition of cPLA2 mimics or modulates Dex-induced apoptosis.
  • To elucidate the downstream signaling pathways involved in cPLA2 inhibition-induced apoptosis.

Main Methods:

  • Pharmacological inhibition of cPLA2 using arachidonyl trifluoromethyl ketone (AACOCF3) and palmitoyl trifluoromethyl ketone (PACOCF3).
  • Assessment of thymocyte apoptosis using established assays.
  • Inhibition studies using specific inhibitors for phospholipase C beta (PI-PLCbeta) and phospholipase C (PC-PLC).
  • Measurement of diacylglycerol (DAG) generation.
  • Enzyme activity assays for acidic sphingomyelinase (aSMase) and neutral sphingomyelinase (nSMase).
  • Quantification of ceramide levels.
  • Caspase 3 activity assays and inhibition studies.

Main Results:

  • Inhibition of cPLA2 with AACOCF3 and PACOCF3 induced significant thymocyte apoptosis, comparable to Dex treatment.
  • Secretory PLA2 inhibition with p-bromophenacyl bromide (pBPB) did not induce apoptosis.
  • AACOCF3-induced apoptosis was dependent on PI-PLCbeta, not PC-PLC, and correlated with increased DAG generation.
  • AACOCF3 induced aSMase activation, increased ceramide levels, and caspase 3 activation.
  • Monensin inhibited AACOCF3-induced apoptosis, suggesting aSMase involvement.
  • Caspase 3 inhibition blocked AACOCF3-induced apoptosis.

Conclusions:

  • cPLA2 inhibition plays a significant role in inducing thymocyte apoptosis, mimicking Dex effects.
  • The apoptotic pathway involves PI-PLCbeta, DAG generation, aSMase activation, ceramide production, and caspase 3 activation.
  • cPLA2 activity is crucial for thymocyte survival.

More Related Videos

Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis09:44

Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis

Published on: October 14, 2025

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...